The fibulins are an emerging family of extracellular matrix and blood proteins presently having two members designated fibulin-1 and -2. Fibulin-1 is the predominant fibulin in blood, present at a concentration of 30-40 µg/ml (1000-fold higher than fibulin-2). During the course of isolating fibulin-1 from plasma by immunoaffinity chromatography, a 340-kDa polypeptide was consistently found to co-purify. This protein was identified as fibrinogen (Fg) based on its electrophoretic behavior and reactivity with Fg monoclonal antibodies. Radioiodinated fibulin-1 was shown to bind to Fg transferred onto nitrocellulose filters after SDS-polyacrylamide gel electrophoresis. In enzyme-linked immunosorbent assay, fibulin-1 bound to Fg (and fibrin) adsorbed onto microtiter well plastic, and conversely, Fg bound to fibulin-1-coated wells. The binding of Fg to fibulin-1 was also observed in surface plasmon resonance assays, and a dissociation constant (K) of 2.9 ± 1.6 µM was derived. In addition, fluorescence anisotropy experiments demonstrated that the interaction was also able to occur in fluid phase, which suggests that complexes of fibulin-1 and Fg could exist in the blood. To localize the portion of Fg that is responsible for interacting with fibulin-1, proteolytic fragments of Fg were evaluated for their ability to promote fibulin-1 binding. Fragments containing the carboxyl-terminal region of the B chain (residues 216-468) were able to bind to fibulin-1. In addition, it was found that fibulin-1 was able to incorporate into fibrin clots formed in vitro and was immunologically detected within newly formed fibrin-containing thrombi associated with human atherectomy specimens. The interaction between fibulin-1 and Fg highlights potential new roles for fibulin-1 in hemostasis as well as thrombosis.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				X. Luo, L. Ding, and N. Chegini CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-{beta} and regulation by TGF-{beta} in leiomyoma and myometrial smooth muscle cells Mol. Hum. Reprod., April 1, 2006; 12(4): 245 - 256. [Abstract] [Full Text] [PDF]

				Y. Xiang, T. Sekine, H. Nakamura, S. Imajoh-Ohmi, H. Fukuda, K. Yudoh, K. Masuko-Hongo, K. Nishioka, and T. Kato Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol., March 1, 2006; 176(5): 3196 - 3204. [Abstract] [Full Text] [PDF]

				N. V. Lee, J. C. Rodriguez-Manzaneque, S. N.-M. Thai, W. O. Twal, A. Luque, K. M. Lyons, W. S. Argraves, and M. L. Iruela-Arispe Fibulin-1 Acts as a Cofactor for the Matrix Metalloprotease ADAMTS-1 J. Biol. Chem., October 14, 2005; 280(41): 34796 - 34804. [Abstract] [Full Text] [PDF]

				H. Thibout, C. Martinerie, C. Creminon, F. Godeau, P. Boudou, Y. Le Bouc, and M. Laurent Characterization of Human NOV in Biological Fluids: An Enzyme Immunoassay for the Quantification of Human NOV in Sera from Patients with Diseases of the Adrenal Gland and of the Nervous System J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 327 - 336. [Abstract] [Full Text] [PDF]

				W. P. Schiemann, G. C. Blobe, D. E. Kalume, A. Pandey, and H. F. Lodish Context-specific Effects of Fibulin-5 (DANCE/EVEC) on Cell Proliferation, Motility, and Invasion. FIBULIN-5 IS INDUCED BY TRANSFORMING GROWTH FACTOR-beta AND AFFECTS PROTEIN KINASE CASCADES J. Biol. Chem., July 19, 2002; 277(30): 27367 - 27377. [Abstract] [Full Text] [PDF]

				W. O. Twal, A. Czirok, B. Hegedus, C. Knaak, M. R. Chintalapudi, H. Okagawa, Y. Sugi, and W. S. Argraves Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility J. Cell Sci., March 14, 2002; 114(24): 4587 - 4598. [Abstract] [Full Text] [PDF]

				P Debeer, E F P M Schoenmakers, W O Twal, W S Argraves, L De Smet, J-P Fryns, and W J M Van de Ven The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly J. Med. Genet., February 1, 2002; 39(2): 98 - 104. [Abstract] [Full Text] [PDF]

				G. Kostka, R. Giltay, W. Bloch, K. Addicks, R. Timpl, R. Fassler, and M.-L. Chu Perinatal Lethality and Endothelial Cell Abnormalities in Several Vessel Compartments of Fibulin-1-Deficient Mice Mol. Cell. Biol., October 15, 2001; 21(20): 7025 - 7034. [Abstract] [Full Text] [PDF]

				P. N Robinson and M. Godfrey The molecular genetics of Marfan syndrome and related microfibrillopathies J. Med. Genet., January 1, 2000; 37(1): 9 - 25. [Abstract] [Full Text]

				B. Perbal, C. Martinerie, R. Sainson, M. Werner, B. He, and B. Roizman The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: A clue for a role of NOVH in cell-adhesion signaling PNAS, February 2, 1999; 96(3): 869 - 874. [Abstract] [Full Text] [PDF]

				P. Roger, P. Pujol, A. Lucas, P. Baldet, and H. Rochefort Increased Immunostaining of Fibulin-1, an Estrogen-Regulated Protein in the Stroma of Human Ovarian Epithelial Tumors Am. J. Pathol., November 1, 1998; 153(5): 1579 - 1588. [Abstract] [Full Text] [PDF]

				S. A. Corbett, L. Lee, C. L. Wilson, and J. E. Schwarzbauer Covalent Cross-linking of Fibronectin to Fibrin Is Required for Maximal Cell Adhesion to a Fibronectin-Fibrin Matrix J. Biol. Chem., October 3, 1997; 272(40): 24999 - 25005. [Abstract] [Full Text] [PDF]

				G. Guadiz, L. A. Sporn, and P. J. Simpson-Haidaris Thrombin Cleavage-Independent Deposition of Fibrinogen in Extracellular Matrices Blood, October 1, 1997; 90(7): 2644 - 2653. [Abstract] [Full Text] [PDF]

				H. Tran, W. J. VanDusen, and W. S. Argraves The Self-association and Fibronectin-binding Sites of Fibulin-1 Map to Calcium-binding Epidermal Growth Factor-like Domains J. Biol. Chem., September 5, 1997; 272(36): 22600 - 22606. [Abstract] [Full Text] [PDF]